nafamostat has been researched along with Glomerulonephritis in 8 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea." | 5.31 | Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient. ( Iseki, K; Ishida, A; Mano, R; Muratani, H; Oshiro-Chinen, S; Sakima, A; Takishita, S; Tana, T; Tomiyama, N; Tozawa, M; Yamazato, M, 2002) |
| "Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea." | 1.31 | Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient. ( Iseki, K; Ishida, A; Mano, R; Muratani, H; Oshiro-Chinen, S; Sakima, A; Takishita, S; Tana, T; Tomiyama, N; Tozawa, M; Yamazato, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamazato, M | 1 |
| Mano, R | 1 |
| Oshiro-Chinen, S | 1 |
| Tomiyama, N | 1 |
| Sakima, A | 1 |
| Ishida, A | 1 |
| Tana, T | 1 |
| Tozawa, M | 1 |
| Muratani, H | 1 |
| Iseki, K | 1 |
| Takishita, S | 1 |
| Nagai, H | 1 |
| Yamada, H | 1 |
| Matsuura, N | 1 |
| Inagaki, N | 1 |
| Shimazawa, T | 1 |
| Koda, A | 1 |
| Yaoita, E | 1 |
| Kawasaki, K | 1 |
| Yamamoto, T | 1 |
| Kihara, I | 1 |
| Miyata, T | 2 |
| Fujita, Y | 2 |
| Inagi, R | 2 |
| Inoue, I | 2 |
| Sugiyama, S | 2 |
| Maeda, K | 2 |
| Shinzato, T | 1 |
| Miyama, A | 1 |
| Porcel, JM | 1 |
| Ueda, M | 1 |
| Deguchi, M | 1 |
| Takemura, S | 1 |
| Kasamatsu, Y | 1 |
| Yanagida, K | 1 |
| Fukuda, W | 1 |
| Okamoto, M | 1 |
| Onodera, H | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
| Ikehara, S | 1 |
| Shimamura, K | 1 |
| Aoyama, T | 1 |
| Fujii, S | 1 |
| Hamashima, Y | 1 |
8 other studies available for nafamostat and Glomerulonephritis
| Article | Year |
|---|---|
Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient.
Topics: Abdominal Pain; Adult; Anticoagulants; Benzamidines; Drug Hypersensitivity; Female; Fibrinolysin; Gl | 2002 |
The effect of 6-amidino-2-naphtyl-4-guanidinobenzoate dimethane sulfonate (FUT-175) on experimental glomerulonephritis in mice.
Topics: Animals; Benzamidines; Complement Inactivator Proteins; Cyclophosphamide; Disease Models, Animal; Fe | 1984 |
[Effect of FUT-175 on rat experimental nephritis. II. Rat BSA nephritis].
Topics: Animals; Antigen-Antibody Complex; Benzamidines; Complement Inactivator Proteins; Glomerulonephritis | 1984 |
Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
Topics: Benzamidines; Complement Inactivator Proteins; Cryoglobulinemia; Glomerulonephritis; Guanidines; Hum | 1993 |
Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.
Topics: Adult; Benzamidines; Child; Complement Activation; Complement Inactivator Proteins; Complement Syste | 1993 |
[Complement inhibition: a new therapeutic modality?].
Topics: Adult; Animals; Antigens, CD; Benzamidines; Blood Proteins; Carrier Proteins; CD55 Antigens; CD59 An | 1995 |
[The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
Topics: Aged; Aged, 80 and over; Benzamidines; Cells, Cultured; Chronic Disease; Complement C3; Complement C | 1991 |
Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
Topics: Animals; Autoimmune Diseases; Benzamidines; Female; Glomerulonephritis; Guanidines; Lupus Erythemato | 1985 |